Enhanced Healthcare Partners and Bourne Partners Strategic Capital Sells PAI Pharma

SANTA MONICA, CA (February 24, 2025) — Enhanced Healthcare Partners (“EHP”) and Bourne Partners Strategic Capital (“BPSC”), two leading healthcare-focused private equity firms, are pleased to announce the successful sale of their platform investment, PAI Pharma (“PAI” and the “Company”), through the sale of the business to Olympus Partners.

PAI, the leading developer, manufacturer, and distributor of generic oral liquids in both ready-to-dose (“RTD”) cups and bottles in the U.S., offers the broadest portfolio of generic liquid medicines in the industry meeting the unique needs of retail chains, independent pharmacies, hospitals, long-term care facilities, and government agencies. Over the past five years, the Company has deeply invested in facility expansion, infrastructure, automation, and quality to support the Company's growth. PAI is headquartered in Parsippany, NJ, and operates from two large campuses in Greenville, SC. 

Kurt Orlofski, CEO of PAI, added, “The team and I are thrilled to partner with Olympus as we continue our evolution as a company. Given their experience and success, we are certain they will be invaluable partners as we look to accelerate our growth.”

In speaking about PAI’s partnership with EHP and BPSC, he continued, “We benefited tremendously from our relationships with both firms and are grateful for their insight and support.” Matt Thompson, General Partner at EHP said, “We are proud of what PAI and the team accomplished throughout our partnership and are honored to have played a role assisting the Company in its expansion and growth initiatives. We wish Kurt—and the rest of the management team—the best of luck in this next stage of growth and could not be more confident in PAI's ability to continue its trajectory of growth and innovation.”

Minor Hinson, Head of Private Equity at BPSC commented, “The successful partnership with PAI employees, the management team, and EHP has been incredibly rewarding and is a compelling example of our core strategy. We know the entire team at PAI is primed for its next phase of growth.” Banks Bourne, Founder of BPSC and Bourne Partners said, “We saw an incredible opportunity to support and expand the PAI team while working with EHP and management to grow the business. We wish the Company well in its new partnership with Olympus.”

Terms of the transaction were not disclosed. RBC Capital Markets, LLC and Bourne Partners acted as financial advisors to PAI on the sale.

About Enhanced Healthcare Partners

Enhanced Healthcare Partners is a leading healthcare-focused private equity firm dedicated to making minority and majority investments in founder and entrepreneur-led middle-market companies. The EHP team has managed approximately $1 billion in equity capital and is comprised of professionals with deep healthcare, operations, consulting and investment management experience. The firm seeks to invest in companies between $50-$250 million in enterprise value, driving deep partnerships with management and founders to catalyze growth and build great organizations

About Bourne Partners Strategic Capital ("BPSC")
Headquartered in Charlotte, N.C., Bourne Partners Strategic Capital is a private equity and growth equity investment firm focused exclusively on the pharmaceutical, pharma services and consumer healthcare sectors. As owners and operators with over 20 years of experience, BPSC has investment, strategic and operational experience in companies ranging from $5 million to $3 billion in equity value and seeks to align and partner with management teams and other owners in these sectors to grow their businesses. For more information, please visit https://www.bourne-partners.com/strategic-capital/

Bourne Partners is a financial services firm specializing in the pharma, pharma services, OTC and consumer health sectors. Located in Charlotte, North Carolina, the company offers investment banking and advisory services. As owners and operators with over 20 years of experience, Bourne Partners strives to enrich the lives and improve the health and well-being of their partners and patients across the globe by facilitating the efficient movement of capital through the global healthcare sector.